Ledger.Open graph →
SEC Form D · filed August 19, 2024

Lytica Therapeutics, Inc

Offering
—
Sold
$1.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Daniel Macaya · CAMBRIDGE, MADirectorJames Latorre · CAMBRIDGE, MADirectorRida Mourtada · CAMBRIDGE, MAExec · DirectorJean-Francois Ducrest · CAMBRIDGE, MADirectorRida Mourtada · CAMBRIDGE, MAExec · DirectorJean-Francois Ducrest · CAMBRIDGE, MADirectorJames Latorre · CAMBRIDGE, MADirectorDaniel Macaya · CAMBRIDGE, MADirectorGlenn Argenbright · Aventura, FLDirectorRonald Buschur · Aventura, FLDirectorMaynard Hellman · Aventura, FLExec · DirectorNelson E. Lamis · Aventura, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗